Table 1.

Subgroup Analyses for AIHS Responder Rates at Month 3 (mITT Population)

Characteristic	VYC-15L	Control
Sex, n (%)
Female	76/91 (83.5)	5/31 (16.1)
Male	8/10 (80.0)	0/1 (0.0)
Race, n (%)
Nonwhite	20/22 (90.9)	0/5 (0.0)
White	64/79 (81.0)	5/27 (18.5)
Fitzpatrick skin type subset, n (%)
I/II	29/34 (85.3)	0/11 (0.0)
III/IV	40/50 (80.0)	5/18 (27.8)
V/VI	15/17 (88.2)	0/3 (0.0)
Baseline AIHS score, n (%)
Moderate	34/39 (87.2)	2/14 (14.3)
Severe	50/62 (80.6)	3/18 (16.7)

AIHS, Allergan Infraorbital Hollows Scale; mITT, modified intent-to-treat.